270
Participants
Start Date
December 29, 2023
Primary Completion Date
November 26, 2024
Study Completion Date
December 16, 2024
3 ampoules of SHPL-49 Injection
3 ampoules of SHPL-49 Injection in 100 mL 0.9% sodium chloride will be administered as a 30-minute IV infusion and applied twice daily for 7 days.
6 ampoules of SHPL-49 Injection
6 ampoules of SHPL-49 Injection in 100 mL 0.9% sodium chloride will be administered as a 30-minute IV infusion and applied twice daily for 7 days.
0.9% Sodium Chloride Injection
100 mL 0.9% sodium chloride will be administered as a 30-minute IV infusion and applied twice daily for 7 days.
Beijing Tiantan Hosptial，Capital Medical University, Beijing
Shenyang Medical College Affiliated Central Hospital, Shenyang
The First People's Hospital of Shenyang, Shenyang
Beipiao Central Hospital, Beipiao
The First Hospital of Jilin University, Changchun
Linyi People's Hospital, Linyi
The First People's Hospital of Tancheng, Linyi
General Hospital of Pingmei Shenma Group, Pingdingshan
Nanshi Hospital of Nanyang, Nanyang
Yuebei People's Hospital, Shaoguan
Hengshui People's Hospital, Hengshui
Tangshan Workers' Hospital, Tangshan
Keshiketeng Banner Traditional Chinese Medicine and Mongolian Medicine Hospital, Chifeng
Sinopharm Tongmei General Hospital, Datong
Linfen Central Hospital, Linfen
Linfen People's Hospital, Linfen
Beijing Tiantan Hospital
OTHER
Shanghai Hutchison Pharmaceuticals Limited
INDUSTRY